Skip to main content
OCUL $5.94 +0.00%
OCUL logo
OCUL · Ocular Therapeutix, Inc
Track OCUL — free
$5.94 +0.00 (+0.00%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.31B
Shares
220.02M
Volume · Nov 19 304.36K Avg daily vol (3M) 3.04M
All webcasts

Earnings call · FY2024 Q1

Ocular Therapeutix, Inc (OCUL) Q1 2024 Earnings Call

Concluded May 7, 2024
May 7, 2024
Period
FY2024 Q1
Runtime
—
Sources
2 artifacts
Revenue $14.77M +10.5% YoY
Diluted EPS -$0.49
Gross margin · derived Q4 91.0% +0.1 pp YoY
Net income -$64.85M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$14.71M +11.4% YoY
Collaboration Revenue$59,000 -63.1% YoY
Full-screen source Call document